Catalent says its GPEx Lightning platform can save up to twelve weeks on customer program timelines by combining multiple technologies into a single process. Contract development manufacturing organization (CDMO) Catalent has created GPEx Lightning, which it says combines gene insertion activities to minimize drug substance development time by up to three months. The tech is based on its long-standing GPEx tech platform. “By adapting the cell line and incorporating some enhancements into the process, we were able to increase the…

Kriya Therapeutics will use $100 million from a Series B funding to develop its gene therapy manufacturing platforms and says its GMP plant in North Carolina will come online this year. The Series B financing – led by Patient Square Capital, with participation from new investors Woodline Partners LP, CAM Capital, Hongkou, Alumni Ventures and others – closed earlier this month. The funding will help support Kriya’s gene therapy platforms and manufacturing infrastructure, which aim to reduce the cost of…

Catalent will add biologics drug substance production capabilities to its Italian plant, which it says will support demand from the European market. The $100 million investment will see contract development manufacturing organization (CDMO) Catalent install two 2,000 L single-use bioreactors in newly constructed manufacturing suites at its Anagni, Italy facility it acquired from Bristol Myers Squibb in June 2019. Additionally, the firm will build infrastructure required to house a further six 2,000 L single-use bioreactors and the first phase of…

Regeneron will invest $1.8 billion over six years to expand its manufacturing, support, and research facilities in New York. According to a press release from the New York Governor’s office, Regeneron plans to expand its R&D facilities at the firm’s Westchester Country Campus in Tarrytown. The investment encompasses Regeneron’s plans that were announced in April to inject $480 million to construct a preclinical facility at its Tarrytown campus. “This new investment in our workforce and laboratory spaces will allow for…

Recipharm will build a fill-finish facility in Uttarakhand, India increasing its fill-finish capacity to one billion sterile units per year. Contract development manufacturing organization (CDMO) Recipharm will construct the new facility on a greenfield site located near Dehradun in Uttarakhand as part of a joint project with Sobti. The Uttarakhand facility is the latest development in Recipharm’s partnership with Sobti, which began in November 2019 when the CDMO invested in Nichepharm. “This is part of our strategy to increase our…

Thermo Fisher Scientific has set out to capture a larger share of the growing DNA therapy and RNA vaccine market with a new facility in California. The facility – a 67,000-square-foot facility located at Thermo’s Carlsbad campus – will supply plasmid DNA for drug candidates in clinical trials as well as commercial supply. The firm cited growing global demand for plasmid DNA-based therapies and vital mRNA-based vaccines as the driver for the investment. CEO Marc Casper said, “Demand for commercial plasmid DNA…

Ardena says the investment is driven by business growth, capacity needs and its ambition to become a leading mid-sized CDMO. In partnership with GHO Capital, contract development manufacturing organization (CDMO) Ardena has invested $35 million to expand its European operations in Belgium, Sweden, and the Netherlands to ensure the firm can offer end-to-end solutions. “All expansion work is expected to be complete by Q1 in 2023,” Gerjan Kemperman COO at Ardena told BioProcess Insider. The firm will expand its drug product…

SP has opened a large-scale facility in Barcelona, Spain doubling its global manufacturing capacity for fill-finish services. SP Scientific Products (SP) said that in order to meet the increasing demand for fill-finish and lyophilization (freeze dryer) equipment, it has more than doubled its global manufacturing capacity. The new 4,000 meter Barcelona plant will be equipped to offer fill-finish services and SP is also upping its production headcount and restructuring its manufacturing processes. “This is a multi-million-euro investment including the new…